NCT06783829View on ClinicalTrials.gov

A Study of SHR-4394 Injection in Subjects With Prostate Cancer

PHASE1RecruitingINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Prostate Cancer

Interventions

DRUG

SHR4394

SHR4394

Trial Locations (1)

610041

RECRUITING

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY